Business
Innovest Global, Inc. Forms Biotech Subsidiary To Be Led By World-Renowned Neuroscientist, Dr. Dwain Morris-Irvin - Spotlight Growth
Innovest Global, Inc. Forms Biotech Subsidiary To Be Led By World-Renowned Neuroscientist, Dr. Dwain Morris-Irvin - Spotlight Growth.
About this update from Innovest Global Inc
[{"type":"text","content":"\n\n Sacramento, CA, March 07, 2018 (GLOBE NEWSWIRE) -- A new report has been published on Innovest Global, Inc. (OTC Pink: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The company’s planned subsidiaries operate across telehealth, biotech, commercial energy, business-to-business distribution, national call center and auto sales.\n The report provides an overview of Innovest Global, Inc., its subsidiaries, financials, industry analysis and more. The content also covers the global outlook for the biotechnology industry.   Global Biotech Industry Forecast to Reach $727.10 Billion By 2025 The fight against the next major outbreak will heavily rely on biotechnology in order to effectively find a treatment or cure. This makes biotech one of the key frontiers against emerging health threats, such as viruses and drug-resistant bacteria.  Without an aggressive effort to research and develop (R&D) treatments to fight some of the largest threats to humanity, we risk reliving deadly periods in history such as the “Black Death.” The pandemic wiped out 50 million people in the 14th century, which equated to 60% of Europe’s population at the time of the plague outbreak. According to Grand View Research, Inc., the global biotechnology market is forecast to hit $727.10 billion by 2025. The firm notes that the growth will most likely be generated by regenerative medicines and genetics in diagnostics. Grand View further notes that technological advances are helping biotech companies with greater R&D and clinical testing capabilities. Overall, this will help with advancing treatments and research methods. Innovest Launching New Biotech and Health Sciences Division This Spring, Will Be Headquartered in Los Angeles, CA  Innovest Global, Inc. recently announced that it is preparing to launch a new biotechnology and health sciences division this spring, which will be headquartered in Los Angeles, CA. The new division will be led by world-renowned neuroscientist, Dr. Dwain Morris-Irvin. Dr. Morris-Irvin received his PhD from the UCLA School of Medicine and Masters in Public Health from UCLA School of Public Health. Furthermore, the distinguished neuroscientist trained at The Wa...